Beruflich Dokumente
Kultur Dokumente
www.grcts.com
11/18/2016
www.grcts.com
11/18/2016
While the requirement to have a CER is not new, it is subject to more intense scrutiny
by Notified Bodies in the conformity assessment phase, and CERs are increasingly
being assessed in the post-market phase. This revised MEDDEV is being generated
within a context of increased scrutiny on the Notified Bodies. The revision of this
document represents a complete re-write of this MEDDEV, with many new
Appendices and much new guidance. The new MEDDEV can be considered more
instructive, but also more prescriptive in particular regarding the use of evidence
from equivalent devices.
www.grcts.com
11/18/2016
scrutiny on the Notified Bodies (NB) by the Joint Assessments from the
Competent Authorities, which has led to an increase in the level of
review the NB exercise over clinical evaluation
Frequency for updating the CER is also much more prescriptive now
and you must define and justify the frequency, based on significant
risk of the device, as well as how well-established
11/18/2016
11/18/2016
www.grcts.com
11/18/2016
Regulatory Affairs
RA Specialists
Clinical Affairs
Project Leaders for MEDDEV Compliance
Quality Control/Quality Assurance
Compliance
Marketing & Sales
Distributors/Authorized Representatives
Engineering/Technical Services
Consultants
Manufacturing
Auditors
www.grcts.com
11/18/2016
Instructor Profile:
David R. Dills, Global Regulatory Affairs & Compliance Consultant currently provides
regulatory affairs, compliance and quality consultative services for early-stage and
established Class I/II/III device, In Vitro Diagnostics, cosmetics and bio/pharmaceutical
manufacturers on the global landscape, and also has an accomplished record with more
than 25 years of experience in the areas of Regulatory Affairs, Compliance and Quality
Systems. He has been previously employed, with increasing responsibilities by medical
device manufacturers and consultancies, including a globally recognized CRO and has
worked directly with manufacturers engaged in compliance remediation activities and
services involving consent decrees, CIAs, warning letters, 483 observations, and customer
generated compliance events, and prepares for and conducts QS and regulatory audits.
www.grcts.com
11/18/2016
www.grcts.com
11/18/2016
www.grcts.com
11/18/2016
www.grcts.com
11/18/2016
competing
priorities
operations/commercial
having
opportunities.
direct
Develops
impact
on
site
strategies
for
11/18/2016
Mr. Dills manages regulatory problems (e.g. AEs, MDRs, Agency enforcement, and
complaints) related to development, manufacturing, and commercialization, and
recommends action to senior leadership to ensure effective resolution for
manufacturers to achieve sustainable and proven compliant systems. Background
encompasses broad capabilities in quality systems; documentation development and
remediation; RA/RC oversight and governance; design controls; CAPA/investigations;
GxP training; software and process validation with compliance oversight; supplier
management; interfaces with FDA and other Agencies on the regulatory landscape;
compliance with MDD/IVDD Directives and Technical File/Design Dossier and CE
Mark requirements; and demonstrates credible experience to optimize business
performance through proactive strategies to mitigate compliance exposure.
www.grcts.com
11/18/2016
11/18/2016
He provides direction on understanding the regulatory landscape for the product and
provides a fully integrated approach to device development including design controls,
and effective communications with Regulatory Authorities related to product
development and post-marketing activities.
Mr. Dills has served on the Faculty Advisory Board for the Pharmaceutical Training
Institute, Editorial Advisory Boards for Software Quality Professional and the
Institute of Validation Technology (IVT), publisher of the Journal of GXP Compliance
and Journal of Validation Technology and on the Readers Board for Medical Device
& Diagnostic Industry and Medical Product Manufacturing News and was nominated
and accepted for inclusion into the 2005-2006 Strathmores Whos Who of
Professionals.
www.grcts.com
11/18/2016
Mr. Dills has authored and published validation, regulatory and compliance-related
articles, commentaries and technical guides, and is an accomplished global industry
presenter. Mr. Dills academic degrees include Environmental Science and Biology.
He is a former Chair and Co- Chair of ASQs Section 1506 and associated with the
Biomedical Division, RAPS, AdvaMed, PDA, ISPE, and other industry working
groups.
www.grcts.com
11/18/2016